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Abstract Nucleoli are the sites where synthesis of rRNA
and ribosomal assembly take place. Along with these “tra-
ditional” roles, the nucleolus controls cellular physiology
and homeostasis. The cellular and molecular alterations
associated with impaired nucleolar activity (“nucleolar
stress”) have just started to be systematically explored in
the nervous system taking advantage of newly available
animal models lacking rRNA synthesis in specific neurons.
These studies showed that nucleolar function is necessary
for neuronal survival and that its modality of action differs
between and within cell types. Nucleolar function is also
crucial in pathology as it controls mitochondrial activity and
critical stress signaling pathways mimicking hallmarks of
human neurodegenerative diseases. This mini-review will
focus on the modes of action of nucleolar stress and discuss
how the manipulation of nucleolar activity might underscore
novel strategies to extend neuronal function and survival.
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Non-traditional roles of the nucleolus
under physiological conditions
Nucleoli are non-membrane-bound structures within the
nucleus where ribosomal RNA (rRNA) genes are transcribed.
These atypical cellular organelles consist of three major
compartments with specific functions: (1) fibrillar centers
(FC, pre-rRNA synthesis), (2) dense fibrillar components
(DFC, pre-RNA processing), and (3) granular components
(GC, ribosome assembly). Their organization allows
hosting a number of proteins and RNAs with an impor-
tant role in various cellular processes. Thus the pertur-
bation of nucleolar dynamic assembly exerts profound
effects on several cellular functions [1]. A detailed
description of nucleolar morphology and organization
has been provided elsewhere [1, 2]. Here we focus on
the mechanisms by which nucleolar activity may regulate
neuronal function and survival and contribute especially
to neurodegenerative diseases.
One intriguing mechanism to control embryonic devel-
opment, differentiation, and survival is the nucleolar shut-
tling of cell cycle regulators and transcription factors
dictating cell lineage to the nucleoplasm [1]. Moreover,
rRNA repression seems required for the execution of differ-
entiation programs. For example, during the embryonic
development, transcription of rRNA genes is repressed by
lineage-commitment transcription factors turning off the
pluripotency genes [3]. During neural lineage commitment
there is no direct evidence that rRNA transcription is
inhibited; it is likely, however, that mechanisms involving
nucleolar dynamics could be in play. For example in brain
and retina the levels of the nucleolar protein nucleostemin, a
controller of pre-rRNA processing, are rapidly reduced
before cell cycle exit and neural differentiation [4, 5], sug-
gesting that rRNA biosynthesis may have a regulatory effect
on neurogenesis.
However, the major regulatory function associated with
altered dynamics of nucleolar proteins is connected to the
stress response and involves among others the release of
ribosomal proteins (RPs) to the nucleoplasm. In response to
adverse growth conditions, metabolic deficits, and oxidative
stress, rRNA synthesis is downregulated by mechanisms
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involving transcription factors and epigenetic modifications
[6]. This perturbation of nucleolar activity and integrity has
been defined “nucleolar stress” [7]. Disruption of ribosome
biogenesis releases RPs such as L5, L11, L23, and S7 into
the nucleoplasm where they interfere with the activity of the
E3 ubiquitin ligase Mdm2. Normally, this enzyme promotes
proteasomal degradation of the transcription factor p53,
but this function is impaired by RPs leading to accumu-
lation of p53, which in turn initiates transcriptional and
non-transcriptional programs [8]. By sensing cellular
stress signals and transmitting them to the p53 stabiliza-
tion system the nucleolus plays a fundamental role as a
“stress sensor” [9]. Nucleolar stress may affect p53 levels
also by non-RPs. The nucleolar protein nucleophosmin is
dowregulated upon excitotoxic stimuli in neurons and
alters p53 levels. Nevertheless, nucleophosmin-induced
cell death appears to be p53 independent [10], suggesting
that other yet unknown pathways control the stress
response.
More regulatory functions can be postulated based on
the observation that the nucleoli are also composed of
RNAs, which are involved in the processing and matura-
tion of cellular RNAs. For example, small nuclear RNAs
are modified in the nucleolus, suggesting a possible link
between nucleolar activity and splicing regulation [11]. In
mature neurons changes in protein synthesis during syn-
aptic activity are linked to increased number of nucleoli,
by the postsynaptic protein AIDA-1d that regulates the
generation of functional nucleoli by enhancing the release
of small nuclear ribonucleoproteins (snRNPs) to the nu-
cleoli [12].
More recently, a significant number of small non-coding
RNAs (ncRNAs) regulating mRNA translation have been
located in the GC of the nucleolus [13]. Although the role of
this nucleolar transit is not understood, it is tempting to
speculate that the regulation of microRNAs (miRNAs)
processing and location is an additional mechanism
linking nucleolar activity to protein synthesis regulation.
Recently, it has been demonstrated that also specific
stress stimuli such as acidosis and heat shock [14]
induce immobilization of proteins by long ncRNAs in
the nucleolus. In turn, reduced levels of ribosomal pro-
teins may alleviate miRNA-mediated repression of
translation initiation [15], highlighting the finely tuned
cross-talk of the translational components that have their
epicenter in the nucleolus. These premises and the in-
creasing evidence of the role of ncRNAs in neuronal
development and plasticity [16] support the unexplored
functional link between nucleolus and ncRNAs in neu-
ronal survival and activity.
In summary, by sequestering regulatory proteins and
RNAs, and by influencing their dynamics upon specific
stimuli, the nucleolus can finely tune distinct cellular
functions beyond protein synthesis under physiological
conditions.
Disruption of nucleolar activity in neurodegenerative
diseases
It is well known that nucleolar malfunction contributes to
the pathology of several rare human genetic disorders,
such as Werner syndrome, dyskeratosis congenita,
Treacher Collins syndrome and predisposes to certain
forms of cancer [17, 18]. Moreover, decline in rRNA
synthesis and nucleolar size occur during aging, which is
the principal risk factor for neurodegenerative diseases
[19, 20]. One of the major problems in neurodegenerative
diseases is that the majority of cases are sporadic and,
even when an inherited basis is ascertained, there is a high
inter-individual variability. Thus, major efforts are directed
to identify factors influencing disease onset and progres-
sion. Current treatments only help to ameliorate the symp-
toms but treatments that stop or reverse the pathology are
still missing.
The interest on nucleolar stress is gaining momentum and
the number of studies is rapidly growing over the last years
[21] (Fig. 1). A focus on the role of nucleolar stress for
neuronal activity and survival offers a basic and yet trans-
formative perspective to the field of research on neurode-
generation. For example, silencing of rDNA may occur
during early stages of Alzheimer´s disease (AD) pathology
and play a role in AD-related ribosomal deficits and, ulti-
mately, in dementia [22]. In line with this speculation,
differential methylation activity of the human rDNA has
been proposed as a mechanism to decrease rRNA gene
expression in AD patients. Thus, rDNA specific methylation
pattern could be used as a marker of the disease or of its
progression [22].
Nucleolar integrity is disrupted in dopaminergic neu-
rons of Parkinson´s disease (PD) patients in human post-
mortem brain samples [23]. Treatment of mice with the
neurotoxin MPTP (widely used in pharmacological
models of PD to inhibit complex I activity in dopaminergic
neurons), decreases rRNA synthesis causing early nucle-
olar disruption [23]. The findings demonstrating that
impaired mitochondrial activity affects nucleolar func-
tion support the concept that nucleolar stress may occur
at early disease stages and that contributes to the path-
ogenesis. Although the molecular basis of this control is
still not understood, regulators of rRNA transcription
might be involved. In fact, previous studies identified
nucleolin as a protein-regulating rRNA synthesis and
ribosome biogenesis [24, 25] and interacting with
alpha-synuclein and DJ-1, two major proteins involved
in familial PD pathogenesis. Strikingly, the expression
542 J Mol Med (2013) 91:541–547
levels of nucleolin are dramatically reduced in the sub-
stantia nigra pars compacta of human PD patients [26].
More recently, misfolded DJ-1 protein caused by L166P
mutation has been shown to alter rRNA biogenesis in cel-
lular models of PD [27], further supporting the association
of impaired nucleolar activity with PD pathogenesis.
Nucleolar activity and structure are altered also in trinu-
cleotide repeat disorders. These neurodegenerative diseases
are associated with expansion of trinucleotide in repeats
transcribed or untranscribed region of different genes. Hun-
tington’s disease (HD), for instances, is associated with an
expansion in exon 1 of the huntingtin gene, which leads to
an aberrant polyglutamine tract in the huntingtin protein.
Several studies have shown that transcription of rRNA
genes is altered in HD. Rrs1 (regulator of ribosome synthe-
sis), a protein inhibiting transcription of both rRNA and
ribosomal protein genes, is highly expressed in a presymp-
tomatic HD mouse model [28]. The levels of the basal RNA
polymerase I factor UBF1 are decreased in cellular and
animal HD models [29]. In post-mortem specimens of hu-
man HD cases, insoluble aggregates of huntingtin—a hall-
mark of this disorder—are found in the nucleolus [30]. The
presence of insoluble protein aggregates is not limited to HD
and is a rather common feature of neurodegenerative dis-
eases. For instances, aggregates are found in the nucleolus
of spinocerebellar ataxia patients, an inherited disorder
caused by CAG or CTG expansion [30, 31]. In these
neurodegenerative diseases nucleolin appears to play a role
because CAG RNAs deprive rRNA promoter of this
histone chaperone, downregulating rRNA transcription
[32]. Abnormal interaction with nucleolin also accounts
for the neurological disorder ataxia with oculomotor
apraxia type 1, due to mutated aprataxin [33]. In several
human cancers the angiogenic ribonuclease angiogenin
(ANG) is upregulated and acts as a transcription factor,
binding to rRNA promoters and stimulating rRNA tran-
scription. A deficiency in ANG instead causes amyotro-
phic lateral sclerosis and degeneration of motor neurons
[34]. Moreover, nucleolar activity may be repressed by
inhibition of the proteasomal machinery, another hall-
mark of neurodegenerative diseases. RNA protein aggre-
gates form within the nucleolus and are dependent on
nucleolar integrity [35].
Dysfunction of snRNP biogenesis involves protein reloc-
alization to the nucleolus in type I spinal muscular atrophy,
an autosomal recessive disorder leading to degeneration and
death of motor neurons caused by loss or mutations of the
survival motor neuron 1 gene [36].
Mutant RNA molecules downregulating rRNA transcrip-
tion in polyglutamine diseases [32] and mutant proteins
altering the localization of nucleolar proteins in PD [27]
show an active role of mutant gene products to cause rRNA
transcription failure, supporting similar mechanistic studies
in other neurodegenerative disorders. The association of
nucleolar stress with neurodegenerative diseases raises the
question of what cellular and molecular alterations depend
on it.
A lesson from mouse models with nucleolar stress
in specific populations of neurons: similarities
with neuropathological conditions
Recently developed mouse models in which nucleolar func-
tion is specifically impaired have provided the first mecha-
nistic insights into nucleolar stress in the nervous system.
These models are based on the genetic ablation of TIF-IA,
an evolutionary conserved transcription factor essential for
the recruitment of RNA polymerase I to rRNA promoters.
Since its identification, it was evident that TIF-IA activity is
Fig. 1 Diagram showing the
increasing number of
publications and citations
related to nucleolar stress. a
Number of publications found
in PubMed database searching
for “nucleolar + stress”. Only
four out of 39 publications have
been published before the year
2005. b Number of times the
publications in (a) have been
cited; asterisk, last updated on
Aug 31, 2012
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strongly dependent on external signals [37]. By now, it is
known that TIF-IA is regulated by a variety of protein
kinases at distinct serine residues: ERK and RSK in response
to mitogenic signals [38], S6K in response to growth stimuli
[39, 40], JNK2 in response to oxidative stress [41], AMPK in
response to cellular energy status [42], PERK-dependent
phosphorylation in response to endoplasmic reticulum stress
[43] (Fig. 2). In addition, proteasome activity is required for
pre-rRNA synthesis and TIF-IA may represent a potential link
by which proteasomes are recruited to rRNA genes [44].
TIF-IA global knock-out in mice results in early embryonic
lethality [45]. Specific loss of TIF-IA in neural progenitors leads
to rRNA synthesis inhibition, nucleolar disruption, rapid apo-
ptotic death of developing neurons, and consequent anencepha-
lia [46]. The conditional ablation of TIF-IA in mice offers the
major advantage of allowing focused investigation on the im-
pact of nucleolar stress not only on cell cycle and growth
regulation of neural progenitors, but also on quiescent postmi-
totic neurons in living organisms. Inactivation of the TIF-IA
gene in adult dopaminergic neurons by a drug-inducible ap-
proach leads to a phenotype closely resembling PD, character-
ized by depletion of dopamine in the striatum, oxidative stress,
mitochondrial impairment, progressive and differential loss of
dopaminergic neurons in the substantia nigra pars compacta, as
well as marked deficiencies in motor performance [23]. At the
mechanistic level, mTOR activity is downregulated by TIF-IA
ablation in dopaminergic neurons, underscoring a negative
feedback that co-regulate and coordinate the translational pro-
cess. In addition, the p53-dependent apoptosis in proliferating
cells appears to be conserved in dopaminergic neurons under
nucleolar stress, as shown by increased neuronal survival in
absence of p53 [23].
The importance of p53 for the pathogenesis of neurode-
generative diseases has been clearly shown for HD, and
further confirmed also for AD and PD. It is suggested that
p53 could also serve as a convergence point in the molecular
pathways for different neurodegenerative diseases [47]. p53
induces cell cycle arrest, senescence, and apoptosis in re-
sponse to different stress signals such as DNA damage, hyp-
oxia, nutrient deprivation, and nucleolar stress [8]. However,
identifying the key elements that define a particular p53-
mediated stress response outcome remains a central, yet unre-
solved, question. The identification of such downstream effec-
tors is crucial to manipulate the deleterious consequences of
cellular stress mediated by nucleolar disruption.
Future directions and perspectives
Nucleolar stress may start a progressive series of events af-
fecting protein translation, which can be deregulated in con-
sequence of altered distribution of nucleolar proteins and/or
biogenesis of miRNAs, as well as of other cellular mecha-
nisms. Because ribosomes seem to be “specialized” for the
synthesis of specific mRNA [48], nucleolar stress by regulat-
ing ribosomal composition could specifically affect the
Fig. 2 Schematic of the RNA polymerase I machinery at the rDNA
promoters with the different signals and pathways regulating TIF-IA
activity and exerting positive or negative control on nucleolar activity
and integrity
Fig. 3 Summary of the cellular and molecular alterations derived from
nucleolar stress. The “non-traditional” nucleolar roles are depicted as
concentric circles with the early events closer to the nucleolus and
intersecting with the “traditional” nucleolar role in protein synthesis
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translation of particular sets of mRNA in developing and adult
neurons. The activation of p53 and the negative feedback on
mTOR call in play metabolic and survival pathways executing
cell fate decision, by inhibiting mitochondrial function and
protein synthesis (Fig. 3).
The “TIF-IA-based models” will allow exploring initial
adaptive mechanisms to stress conditions and by indirectly
interfering with p53 turnover in specific cells can be used to
gain understanding of context-dependent p53 functions.
Some attempts have been reported to overexpress p53 in a
constitutive and/or inducible way by the generation of trans-
genic mice [49], but engineered mice having high p53
activity in specific cell types are not available because of
the difficulty to generate mutant mice which reproduce the
natural levels of proteins. Ultimately, TIF-IA mutant mice
can be used to develop and validate therapeutic intervention
and identify biomarkers associated with a specific degener-
ative pattern (Table 1). Modulation of the Pol I transcrip-
tional machinery is already proposed for anticancer
therapies either by targeting specific components or the
upstream pathways. Inhibition of Pol I in cancer cells has
been shown to induce their apoptotic death [50]. Intriguing-
ly, the TIF-IA mutant mice have been already useful for
testing the neuroprotective role of the phosphatase PTEN in
dopaminergic neurons, supporting their possible use for
evaluating new therapeutic approaches [51].
Increasing evidence point to a multifactorial basis of
neurodegenerative disease onset and progression. Perhaps
there is time to bridge the gap between the reductionist
approach focused on particular molecules involved in the
pathology of a particular disease. The research for identify-
ing common molecular checkpoints as possible new targets
for pharmacotherapy seems necessary. Despite the total
market of 2.2 billion USD estimated for anti-PD drugs
major pharmaceutical companies discouraged by the rela-
tively little progresses announced cuts to brain disorder
research in favor of sequencing projects to identify genetic
risk factors [52].
Investing more efforts in defining the toxic species causing
rRNA transcription failure and the molecular alterations of
nucleolar stress in specific cellular contexts will shed new
light onto the mechanisms underlying differential vulnerabil-
ity to stress conditions and indicate potential targets to manip-
ulate them. Otherwise there will always be a missing piece in
our understanding of neurological disorders and in our way to
cure them.
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